Webinars

Below is a selection of webinars focused on research tools and grant opportunities. Please visit the Behavioral Research Grants page or the Division of Cancer Control and Population Sciences (DCCPS) Funding Opportunities page for a complete listing of funding opportunities.

Past Webinars

This webinar provided an overview of the new Request for Applications (RFA) Improving Smoking Cessation Interventions among People Living with HIV RFA-CA-18-027 (R01 Clinical Trial Optional) and RFA-CA-18-028 (R21 Clinical Trial Optional).

These RFAs aim to improve cigarette smoking cessation treatment among people living with HIV (PLWH) in the United States. They will support research to systematically test existing evidence-based smoking cessation interventions and/or to develop and test adaptations of evidence-based smoking cessation interventions for application to PLWH.

Application due date: January 8, 2019

Letter of Intent due date: 30 days prior to the application due date

Earliest submission date: December 8, 2018

Speaker:

Annette Kaufman, Ph.D., M.P.H.
Program Director
Tobacco Control Research Branch
Behavioral Research Program
National Cancer Institute (NCI)

Moderator:
Michele Bloch, M.D., Ph.D., Chief, Tobacco Control Research Branch, Behavioral Research Program, NCI

Technical Expert:
Rick Berzon, DrPH., P.A., Program Director, National Institute on Minority Health and Health Disparities

This webinar provided information about new data resources for the Family Life, Activity, Sun, Health, and Eating (FLASHE) study. Speakers discussed:

  • The recently-released GeoFLASHE data set, neighborhood characteristics calculated for use with the FLASHE survey data.
  • Two upcoming releases: An imputation data set for a set of variables in the parent physical activity survey, and a data set of derived variables for the adolescent motion study subsample.

Speakers:

Laura Dwyer, Ph.D.
Cape Fox Facilities Services contractor
in support of the NCI Behavioral Research Program (BRP)
Office of the Associate Director
Behavioral Research Program
National Cancer Institute (NCI)

Youngwon Kim, Ph.D.
Assistant Professor
Department of Health, Kinesiology, and Recreation
College of Health
University of Utah

Benmei Liu, Ph.D.
Mathematical Statistician
Statistical Research and Applications Branch
Surveillance Research Program
National Cancer Institute (NCI)

Linda Nebeling, Ph.D., M.P.H., R.D.
Deputy Associate Director
Behavioral Research Program
National Cancer Institute (NCI)

April Oh, Ph.D., M.P.H.
Program Director
Health Communication and Informatics Research Branch
Behavioral Research Program
National Cancer Institute (NCI)

October 11, 2018, 11:00 a.m.-12:00 p.m. EDT

In this webinar, representatives from three Division of Cancer Control and Population Sciences (DCCPS) programs provided an overview of the funding opportunities below and answered attendee questions.

  • Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (RFA-CA-19-017, U01, Clinical Trial Required): This FOA invites applications for projects aimed at identifying best practices to improve case ascertainment and follow-up care of hereditary cancers, with the goal of improving prevention and detection.
  • Communication and Decision Making for Individuals with Inherited Cancer Syndromes (RFA-CA-19-001, U01, Clinical Trial Optional): This FOA invites applications for projects that develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer so that they can make informed clinical risk management decisions.

Speakers

Erica S. Breslau, Ph.D., M.P.H., Healthcare Delivery Research Program

Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N., Epidemiology and Genomics Research Program

Wendy Nelson, Ph.D., M.P.H., Behavioral Research Program

In the United States, it has been estimated that 3.5% of all cancer deaths are attributable to drinking alcohol. Alcohol drinking is an established risk factor for several malignancies, and it is a potentially modifiable risk factor for cancer.

The American Society of Clinical Oncology (ASCO) recently issued a statement about how alcohol use is linked to cancer risk, treatment, and other cancer-related outcomes, and about ASCO’s efforts to support effective public health strategies in that area. In this webinar, Dr. Noelle K. LoConte, lead author of the ASCO statement, provided an overview of the data and outlined areas where future research is needed.

Speaker

Noelle K. LoConte, M.D.
Associate Professor of Medicine
University of Wisconsin School of Medicine and Public Health

This webinar provided an overview of the funding opportunity announcements Developing Interventions for Health-Enhancing Physical Activity PAR-18-307 (R21/R33 - Clinical Trial Optional) and Testing Interventions for Health-Enhancing Physical Activity PAR-18-324 (R01 - Clinical Trial Optional).

These funding opportunity announcements seek research aimed at developing and testing multi-level physical activity intervention programs acting on at least two levels of the socioecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation.

Dr. Frank Perna and other NIH staff provided an overview of the FOAs and answered questions from prospective applicants.

Speaker

Frank Perna, Ed.D., Ph.D.
Program Director
Health Behaviors Research Branch
Behavioral Research Program

The Division of Cancer Control and Population Sciences (DCCPS) has introduced PAR-18-869: Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) to address scientific challenges in the population sciences that lend themselves to a shorter time span and reduced budget, in the areas of statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health-care delivery, and implementation science.

This FOA also encourages and supports early-stage investigators (ESIs) and aims to grow the ESI applicant pool and portfolio.

In this webinar, representatives from four DCCPS programs provided an overview of the funding opportunity and answered attendee questions.

Speakers

Scott Rogers, M.P.H., Epidemiology and Genomics Research Program

Stefanie Nelson, Ph.D., Epidemiology and Genomics Research Program

Jerry Suls, Ph.D., Behavioral Research Program

Ann Geiger, Ph.D., M.P.H., Healthcare Delivery Research Program

Li Zhu, Ph.D., Surveillance Research Program

Denise Lewis, Ph.D., M.P.H., Surveillance Research Program

This webinar provided an overview of the R01 and R21 funding opportunity announcements (FOA) U.S. Tobacco Control Policies to Reduce Health Disparities. These announcements have been reissued as PAR-18-675 (R01 Clinical Trial Optional) and PAR-18-674 (R21 Clinical Trial Optional).

These FOAs will support research to:

  1. understand how to improve the effectiveness of existing tobacco control policy strategies to reduce health disparities in tobacco use;
  2. study new policy approaches to reduce health disparities in tobacco use.

The National Cancer Institute seeks applications on observational or intervention-based research to reduce health disparities in tobacco use among vulnerable populations in the United States. Specifically, these opportunities intend to stimulate scientific inquiry focused on innovative tobacco control policies. The long-term goal of this funding is to reduce disparities in health outcomes, thereby reducing the excess disease burden of tobacco use within these groups.

National Cancer Institute Speakers:

Richard Moser

Bob Vollinger, MSPH
Program Director
Tobacco Control Research Branch
Behavioral Research Program

Annette Kaufman

Annette Kaufman, PhD, MPH
Program Director
Tobacco Control Research Branch
Behavioral Research Program


Moderator:
Erik Augustson, PhD, MPH
Program Director
Tobacco Control Research Branch
Behavioral Research Program

This webinar discussed aspects of the National Cancer Institute (NCI)-sponsored Family Life, Activity, Sun, Health and Eating (FLASHE) Study, including:

  • Publicly available data sets and resources;
  • methodology and dyadic features of the study design;
  • example findings, such as correlates of health behavior and associations between parents and adolescents on psychosocial and behavioral variables; and
  • opportunities for using FLASHE data.

Speaker:

Laura Dwyer

Laura Dwyer, PhD
Cape Fox Facilities Services contractor in support of the NCI Behavioral Research Program (BRP)

Discussants:
Linda Nebeling, PhD, MPH, RD, BRP, NCI
April Oh, PhD, MPH, BRP, NCI
Frank Perna, EDD, PhD, BRP, NCI
Erin Hennessy, PhD, MPH exit disclaimer, Tufts University

Moderator:
Daniel Bornstein, PhD exit disclaimer
Assistant Professor, Department of Health, Exercise, and Sport Science, The Citadel
Immediate Past Chair, Physical Activity Section, American Public Health Association

This webinar provides an overview of the R01 and R21 funding opportunity announcements, Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery. The announcements have been reissued as PA-18-004 (R01 Clinical Trial Optional) and PA-18-014 (R21 Clinical Trial Optional).

Dr. Wendy Nelson and Ms. Kathleen Castro provide an overview of these funding opportunities that seek research to assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; identify structural, systemic, and psychosocial barriers to adherence; and develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.

Wendy Nelson
Wendy Nelson, PhD, MPH
Program Director
Basic Biobehavioral and Psychological Sciences Branch
Behavioral Research Program
Kelly filipski
Kelly Filipski, PhD, MPH
Program Director
Clinical and Translational Epidemiology Branch
Epidemiology and Genomics Research Program
Kathleen castro
Kathleen Castro, RN, MS, AOCN®
Program Director
Office of the Associate Director
Healthcare Delivery Research Program
Richard Moser

This webinar provides an overview of the R01 and R21 funding opportunity announcement, Cancer-related Behavioral Research through Integrating Existing Data. The announcements have been reissued as PAR-16-256 (R01) and PAR-16-255 (R21).

This funding opportunity announcement (FOA) seeks research that integrates two or more independent data sets to answer novel cancer control and prevention questions. Applicants areeve encouraged to incorporate Integrative Data Analysis (IDA) methods that examine cancer-related behavioral risk factors. Examples of these risk factors include tobacco use, sedentary behavior, poor weight management, lack of medical adherence to screening, and poor vaccine uptake.

Moderator Dr. Jerry Suls provides an overview and background information. Speaker Dr. Richard Moser presents details of the FOA, and technical expert Dr. Michelle Mollica provides information about available data sources.

Todd Horowitz

This webinar provides an overview about the new R01 and R21 funding opportunity announcement, Perception and Cognition Research to Inform Cancer Image Interpretation. The announcements have been reissued as PAR-18-640 (R01 Clinical Trial Optional) and PAR-18-641 (R21 Clinical Trial Optional).

This new funding opportunity aims to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology. The scientific scope of this opportunity will yield insights to improve the accuracy of cancer detection and diagnosis.

Moderator Dr. Paige Green provides an overview and summary of resources. Speaker Dr. Todd Horowitz presents details of the FOA. Drs. Lalitha Shankar and Vinay Pai provide technical assistance.

Mark Parascandola

This webinar provides key information about the R01 and R21 funding opportunity announcements, Tobacco Use and HIV in Low and Middle Income Countries. The announcements have been reissued as PAR-18-023 (R01 Clinical Trial Optional) and PAR-18-022 (R21 Clinical Trial Optional).

Epidemiologist Dr. Mark Parascandola of the National Cancer Institute (NCI) Tobacco Control Research Branch provides an overview of this funding opportunity, which aims to develop and evaluate tobacco cessation interventions tailored to HIV-positive populations - including those with co-morbidities such as tuberculosis (TB) - in low-resource settings in low- and middle-income countries.

Jerry Suls

This webinar provides information about the funding opportunity announcements, Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment. These announcements have been reissued as PAR-18-605 (R01 Clinical Trial Optional). National Cancer Institute Program Director and Senior Scientist, Dr. Jerry Suls, provides an overview.

Key time markers for the presentation:
Introduction and logistics: 0.00
General funding information: 6:50
Cognitive Neuroscience: 23:50
Predicting Behavioral Responses: 28:16
Improving Smoking Cessation: 31:56
New Media Environment: 36:33
Integrating Existing Data: 42:11
Behavioral Intervention: 46:45
Q&A: 64:50

Associate Director of the NCI Behavioral Research Program, Dr. William Klein, provides an overview of these exciting new funding opportunities:

Funding Opportunity Announcements Program Contact

Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment

PAR-18-605 (R01 Clinical Trial Optional)
PAR-18-606 (R21 Clinical Trial Optional)

Jerry Suls

Jerry Suls
240-276-6811
jerry.suls@nih.gov

Predicting Behavioral Responses to Population-Level Cancer Control Strategies

PAR-18-024 (R21 Clinical Trial Optional)

Rebecca Ferrer

Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov

Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions

PAR-18-251 (R01 Clinical Trial Optional)
PAR-18-250 (R21 Clinical Trial Optional)

Yvonne Prutzman

Yvonne Prutzman
240-276-6975
yvonne.hunt@nih.gov

Innovative Approaches to Studying Cancer Communication in the New Media Environment

PAR-18-638 (R01 Clinical Trial Optional)
PAR-18-639 (R21 Clinical Trial Optional)

Kelly Blake

Kelly Blake
240-281-5934
kelly.blake@nih.gov

Cancer-related Behavioral Research through Integrating Existing Data

PAR-16-256 (R01)
PAR-16-255 (R21)

Richard Moser

Richard Moser
240-276-6915
richard.moser@nih.gov

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control

PAR-18-018 (R21 Clinical Trial Optional)

Tanya Agurs-Collins

Tanya Agurs-Collins
240-276-6956
tanya.agurs-collins@nih.gov

Niall Bolger, Ph.D. exit disclaimer, and Jean-Philippe (J-P) Laurenceau, Ph.D. exit disclaimer, introduce viewers to cross-sectional, dyadic analysis using data from the Family Life, Activity, Sun, Health, and Eating (FLASHE) study. Dyadic data present analytic challenges because they have various sources of interdependence (e.g. non-independence between members of the dyad such as a parent and a child). Flexible analytic tools (e.g. path modeling, multilevel modeling) can accommodate these complexities. Viewers will gain introductory-level understanding of dyadic data analysis. Additional resources, such as sample code for preparing data files and conducting dyadic analyses are available on the FLASHE dyadic resources page.

Niall Bolger

Niall Bolger, Ph.D.
Professor of Psychology
Columbia University

Jean-Philippe (J-P) Laurenceau

Jean-Philippe (J-P) Laurenceau, Ph.D.
Professor, Psychological and Brain Sciences
University of Delaware

The webinar features six presentations that address the role of communication science in the development of risk assessment tools and the use of these predictive tools in clinical and research settings. The webinar also presents current challenges and opportunities as risk tools become widely available to patients and the public.

Presentations:

Overview of Prediction Models for Cancer Risk and Susceptibility (4:22 – 23:26)
Andrew Freedman, Ph.D.
Clinical and Translational Epidemiology Branch
Division of Cancer Epidemiology and Genetics
National Cancer Institute

Comments on the Development of the Breast Cancer Risk Assessment Tool (BCRAT or “Gail model 2”) (23:27 – 50:48)
Mitchell Gail, M.D., Ph.D.
Biostatistics Branch
Division of Cancer Epidemiology and Genetics
National Cancer Institute

Making Risk Calculator Outputs Meaningful for Patients (50:50 – 1:33:25)
Brian Zikmund-Fisher, Ph.D.
University of Michigan

Online Risk Assessment Tools in Public Health (1:33:30 - 1:59:10)
Steve Woloshin, M.D., M.S.
Lisa Schwartz, M.D.
Dartmouth Medical School

Your Disease Risk: The Culmination of 17 Years of Transdisciplinary Research (1:59:16 – 2:35:51)
Erika Waters, Ph.D., M.P.H.
Graham Colditz, MD, Dr.P.H.
Hank Dart, M.S.
Washington University in St. Louis, School of Medicine

Risk Assessment and Informed Decision Making: Perspectives from the International Patient Decision Aids Standards Collaboration (IPDAS) (2:36:10 – 3:02:30)
Robert Volk, Ph.D.
MD Anderson Cancer Center

Archived Webinars

AThis webinar provides key information about the R01 funding opportunity announcement, Smoking Cessation within the Context of Lung Cancer Screening (RFA-CA- 15-011 [R01]. Program Director and Statistician Stephanie Land of the National Cancer Institute (NCI) Tobacco Control Research Branch provide an overview of this funding opportunity that aims to support the development and test and/or implementation of smoking cessation interventions delivered to current smokers who undergo low-dose computed tomography (LDCT) lung cancer screening.

See a full listing of our upcoming and past events.